Stefan Dove

2.5k total citations
75 papers, 2.1k citations indexed

About

Stefan Dove is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Stefan Dove has authored 75 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 22 papers in Immunology and 18 papers in Organic Chemistry. Recurrent topics in Stefan Dove's work include Receptor Mechanisms and Signaling (35 papers), Mast cells and histamine (19 papers) and Neuropeptides and Animal Physiology (17 papers). Stefan Dove is often cited by papers focused on Receptor Mechanisms and Signaling (35 papers), Mast cells and histamine (19 papers) and Neuropeptides and Animal Physiology (17 papers). Stefan Dove collaborates with scholars based in Germany, United States and China. Stefan Dove's co-authors include Roland Seifert, Armin Buschauer, Andrea Straßer, Günther Bernhardt, Erich Schneider, Sigurd Elz, Siavosh Mahboobi, Detlef Neumann, Alexander Botzki and Andreas Sellmer and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Stefan Dove

73 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Dove Germany 30 1.5k 589 415 373 210 75 2.1k
David Beidler United States 22 1.1k 0.7× 332 0.6× 242 0.6× 153 0.4× 121 0.6× 30 2.1k
Tony Taldone United States 30 3.0k 2.0× 480 0.8× 280 0.7× 226 0.6× 232 1.1× 65 3.9k
HaJeung Park United States 27 1.7k 1.1× 215 0.4× 270 0.7× 264 0.7× 111 0.5× 68 2.4k
Charles A. Lunn United States 23 979 0.7× 427 0.7× 434 1.0× 117 0.3× 392 1.9× 50 2.4k
John P. Burnier United States 26 2.0k 1.3× 189 0.3× 349 0.8× 298 0.8× 142 0.7× 39 2.9k
Thomas A. Rano United States 12 1.8k 1.3× 419 0.7× 122 0.3× 375 1.0× 77 0.4× 15 2.4k
Kirti Sharma India 23 1.9k 1.3× 361 0.6× 199 0.5× 117 0.3× 206 1.0× 67 3.0k
John P. Mayer United States 28 1.4k 1.0× 785 1.3× 108 0.3× 625 1.7× 317 1.5× 73 3.2k
Mario A. Pagano Italy 29 1.9k 1.3× 206 0.3× 148 0.4× 316 0.8× 152 0.7× 70 2.8k
Qing Huai United States 17 1.2k 0.8× 172 0.3× 155 0.4× 245 0.7× 114 0.5× 23 1.8k

Countries citing papers authored by Stefan Dove

Since Specialization
Citations

This map shows the geographic impact of Stefan Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Dove more than expected).

Fields of papers citing papers by Stefan Dove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Dove. The network helps show where Stefan Dove may publish in the future.

Co-authorship network of co-authors of Stefan Dove

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Dove. A scholar is included among the top collaborators of Stefan Dove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Dove. Stefan Dove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaever, Volkhard, et al.. (2018). cUMP hydrolysis by PDE3B. Naunyn-Schmiedeberg s Archives of Pharmacology. 391(9). 891–905. 4 indexed citations
2.
Sellmer, Andreas, Oliver H. Krämer, Stefan Dove, et al.. (2018). Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors. European Journal of Medicinal Chemistry. 152. 329–357. 36 indexed citations
3.
Kaever, Volkhard, et al.. (2018). Hydrolysis of the non-canonical cyclic nucleotide cUMP by PDE9A: kinetics and binding mode. Naunyn-Schmiedeberg s Archives of Pharmacology. 392(2). 199–208. 4 indexed citations
4.
Dessauer, Carmen, Val J. Watts, Rennolds S. Ostrom, et al.. (2017). International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases. Pharmacological Reviews. 69(2). 93–139. 154 indexed citations
5.
Reinartz, Michael, Timo Littmann, Takeaki Ozawa, et al.. (2014). Structure-bias relationships for fenoterol stereoisomers in six molecular and cellular assays at the β2-adrenoceptor. Naunyn-Schmiedeberg s Archives of Pharmacology. 388(1). 51–65. 14 indexed citations
6.
Braun, Stephan Alexander, et al.. (2011). Design of benzimidazole- and benzoxazole-2-thione derivatives as inhibitors of bacterial hyaluronan lyase. European Journal of Medicinal Chemistry. 46(9). 4419–4429. 39 indexed citations
7.
Schneider, Erich, David Schnell, Andrea Straßer, Stefan Dove, & Roland Seifert. (2010). Impact of the DRY Motif and the Missing “Ionic Lock” on Constitutive Activity and G-Protein Coupling of the Human Histamine H4 Receptor. Journal of Pharmacology and Experimental Therapeutics. 333(2). 382–392. 51 indexed citations
8.
Dove, Stefan, et al.. (2010). Bis-Halogen-Anthraniloyl-Substituted Nucleoside 5′-Triphosphates as Potent and Selective Inhibitors of Bordetella pertussis Adenylyl Cyclase Toxin. Journal of Pharmacology and Experimental Therapeutics. 336(1). 104–115. 20 indexed citations
9.
Ghorai, Prasanta, David Schnell, Sigurd Elz, et al.. (2008). NG‐Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H2 Receptor Agonists. ChemMedChem. 4(2). 232–240. 35 indexed citations
10.
Dove, Stefan, et al.. (2007). Molecular Analysis of the Interaction of Bordetella pertussis Adenylyl Cyclase with Fluorescent Nucleotides. Molecular Pharmacology. 72(3). 526–535. 34 indexed citations
11.
Ghorai, Prasanta, et al.. (2007). Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity. Journal of Pharmacology and Experimental Therapeutics. 321(3). 975–982. 16 indexed citations
12.
Ghorai, Prasanta, et al.. (2007). Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists. Naunyn-Schmiedeberg s Archives of Pharmacology. 376(4). 253–264. 18 indexed citations
13.
Rigden, Daniel J., Alexander Botzki, Ejvis Lamani, et al.. (2006). Design of new benzoxazole-2-thione-derived inhibitors of Streptococcus pneumoniae hyaluronan lyase: structure of a complex with a 2-phenylindole. Glycobiology. 16(8). 757–765. 14 indexed citations
14.
Mahboobi, Siavosh, Andrea Uecker, Andreas Sellmer, et al.. (2006). Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones. Bioorganic & Medicinal Chemistry. 15(5). 2187–2197. 25 indexed citations
15.
Radons, Jürgen, Stefan Dove, Detlef Neumann, et al.. (2003). The Interleukin 1 (IL-1) Receptor Accessory Protein Toll/IL-1 Receptor Domain. Journal of Biological Chemistry. 278(49). 49145–49153. 29 indexed citations
16.
Bürckstümmer, Tilmann, et al.. (2001). Distinct Interaction of Human and Guinea Pig Histamine H2-Receptor with Guanidine-Type Agonists. Molecular Pharmacology. 60(6). 1210–1225. 66 indexed citations
17.
Mahboobi, Siavosh, et al.. (1999). Synthesis of arcyriarubine regioisomers by Pd(0)-catalysis or via lithiated indole derivatives - conformational analysis by semiempirical and X-ray methods. University of Regensburg Publication Server (University of Regensburg). 2 indexed citations
18.
Dove, Stefan & Armin Buschauer. (1998). Imidazolylpropylguanidines as histamine H2 receptor agonists: 3D-QSAR of a large series. Pharmaceutica Acta Helvetiae. 73(3). 145–155. 4 indexed citations
19.
Schuster, Andreas, et al.. (1998). NPY Y1 antagonists: structure–activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures. Regulatory Peptides. 75-76. 9–21. 13 indexed citations
20.
Oehlke, Johannes, et al.. (1983). Darstellung einiger 4- und 5-substituierter Pyridin-2-Carbonsäuren als Fusarsäureanaloga. University of Regensburg Publication Server (University of Regensburg). 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Beidler Breakdown of academic impact, for papers by Tony Taldone Breakdown of academic impact, for papers by HaJeung Park Breakdown of academic impact, for papers by Charles A. Lunn Breakdown of academic impact, for papers by John P. Burnier Breakdown of academic impact, for papers by Thomas A. Rano Breakdown of academic impact, for papers by Kirti Sharma Breakdown of academic impact, for papers by John P. Mayer Breakdown of academic impact, for papers by Mario A. Pagano Breakdown of academic impact, for papers by Qing Huai
Rankless by CCL
2026